Откуда берутся дети? Краткий путеводитель по переходу из лагеря чайлдфри к тихим радостям семейственности Казанцева Ася

27. Alves, A. J. et al. (2016). Physical activity in primary and secondary prevention of cardiovascular disease: overview updated. World Journal of Cardiology, 8 (10), 575–583.

28. Charlton, B. M. et al. (2014). Oral contraceptive use and mortality after 36 years of follow-up in the Nurses’ Health Study: prospective cohort study. The BMJ, 349, g6356.

29. Vessey, M. et al. (2010). Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception, 82, 221–229.

30. Cleland, J. et al. (2012). Contraception and health. Lancet, 380, 149–156.

31. Mansour, D. et al. (2010). Efficacy of contraceptive methods: a review of the literature. The European Journal of Contraception and Reproductive Health Care, 15, 4–16.

32. Bearak, J. et al. (2020). Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. The Lancet Global Health, 8 (9), e1152 – e1161.

33. WHO (2012). Unsafe abortion incidence and mortality. Global and regional levels in 2008 and trends during 1990–2008. https://apps.who.int/iris/bitstream/handle/10665/75173/?sequence=1

34. Здравоохранение в России. 2021: Стат. сб./Росстат. М., 2021.

35. Singh, S. et al. (2018). Abortion worldwide 2017: Uneven progress and unequal access. New York: Guttmacher Institute. https://www.guttmacher.org/report/abortion-worldwide-2017

36. Nowicka, W. (Ed). (2008). Reproductive rights in Poland. The effects of the anti-abortion law. Warsaw: Federation for Women and Family Planning. https://en.federa.org.pl/wp-content/uploads/2018/05/Repro_Rights_in_Poland_report_2008.pdf

37. Lycett, J. E. et al. (2000). Longevity and the costs of reproduction in a historical human population. Proceedings of the Royal Society B, 267 (1438), 31–35.

38. Jasienska, G. et al. (2017). Human reproduction and health: an evolutionary perspective. Lancet, 390, 510–520.

39. Neiger, R. (2017). Long-term effects of pregnancy complications on maternal health: a review. Journal of Clinical Medicine, 6 (8), 76.

40. Slepicka, P. F. et al. (2019). Pregnancy and breast cancer: pathways to understand risk and prevention. Trends in Molecular Medicine, 25 (10), 866–881.

41. Ramlakhan, K. P. et al. (2020). Pregnancy and cardiovascular disease. Nature Reviews. Cardiology, 17 (11), 718–731.

42. Kimber, M. L. et al. (2021). Health outcomes after pregnancy in elite athletes: a systematic review and meta-analysis. Medicine & Science in Sports & Exercise, 53 (8), 1739–1747.

43. Jacobson, L. T. et al. (2018). Breastfeeding history and risk of stroke among parous postmenopausal women in the Women’s Health Initiative. Journal of the American Heart Association, 7 (17), e008739.

44. Tschiderer L. et al. (2022). Breastfeeding is associated with a reduced maternal cardiovascular risk: systematic review and meta-analysis involving data from 8 studies and 1 192 700 parous women. Journal of the American Health Association, 11, e022746.

45. Quashie, N. T. et al. (2019). Childlessness and health among older adults: variation across five outcomes and 20 countries. The Journals of Gerontology: Series B, 76 (2), 348–359.

46. Lacroix, C. (2018). Comparing the relative mitigation potential of individual pro-environmental behaviors. Journal of Cleaner Production, 195, 1398–1407.

47. Wynes, S. & Nicholas, K. A. (2017). The climate mitigation gap: education and government recommendations miss the most effective individual actions. Environmental Research Letters, 12 (7), 074024.

48. Mundaca, L. et al. (2018). Demand-side approaches for limiting global warming to 1.5 °C. Energy Efficiency, 12, 343–362.

49. Halstead, J. & Ackva, J. (2020). Climate & lifestyle report. Founder Pledge. https://founderspledge.com/stories/climate-and-lifestyle-report

50. Bradshaw, C. J. et al. (2021). Underestimating the challenges of avoiding a ghastly future. Frontiers in Conservation Science, 1, 615419.

51. United Nations Department of Economic and Social Affairs, Population Division. (2022). World population prospects 2022: summary of results. http://www.unpopulation.org/

52. Jarzebski, M. P. et al. (2021). Ageing and population shrinking: implications for sustainability in the urban century. NPJ Urban Sustainability, 1, 17.

53. Ord, T. (2014). Overpopulation or underpopulation? In: Is the planet full? Ed. by Goldin, Oxford University Press.

54. Blau, F. D. & Kahn, L. M. (2017). The gender wage gap: extent, trends, and explanation. Journal of Economic Literature, 55 (3), 789–865.

55. Женщины и мужчины России. 2020: Стат. сб. / Росстат. М., 2020.

56. Magnusson, C. & Nermo, M. (2017). Gender, parenthood and wage differences: the importance of time-consuming job characteristics. Social indicators Research, 131, 797–816.

57. International Labour Organization (2019). A quantum leap for gender equality. For a better future of work for all. Geneva. https://www.ilo.org/wcmsp5/groups/public/--dgreports/--dcomm/--publ/documents/publication/wcms_674831.pdf

58. Cukrowska-Torzewska E. & Matysiak, A. (2020). The motherhood wage penalty: a meta-analysis. Social Science Research, 88–89, 102416.

59. Бирюкова С., Макаренцева А. (2017). Оценки “штрафа за материнство” в России. Население и экономика, 1 (1), 50–70.

60. Kwak, E. (2022). The emergence of the motherhood premium: recent trends in the motherhood wage gap across the wage distribution. Review of Economics of the Household, 1, 1–21.

61. Henrik, K. et al. (2018). Children and gender inequality: evidence from Denmark. National Bureau of Economic Research. Working Paper Series, 24219.

62. Plotnick, R. (2009). Childlessness and the economic well-being of older Americans. The Journals of Gerontology: Series B, 64 (6), 767–776.

63. Deming, S. M. (2022). Beyond measurement of the motherhood penalty: how social locations shape mothers’ work decisions and stratify outcomes. Sociology Compass, 16 (6), e12988.

64. Krapf, M. et al. (2017). Parenthood and productivity of highly skilled labor: evidence from the groves of academe. Journal of Economic Behavior & Organization, 140, 147–175.

65. Richards, R. J. (2022). Instinct. In: Encyclopedia of Animal Cognition and Behavior, еd. by Vonk & Shackleford, Springer International Publishing.

66. Lonstein, J. S. et al. (2015). Common and divergent psychobiological mechanisms underlying maternal behaviors in non-human and human mammals. Hormones and behavior, 73, 156–185.

67. Glocker, M. L. et al. (2009). Baby schema modulates the brain reward system in nulliparous women. PNAS, 106 (22), 9115–9119.

68. Wang, T. & Mukhopadhyay, A. (2016). How consumers respond to cute products. In: The Psychology of Design: Creating Consumer Appeal, еd. by Batra, Seifert & Brei, Routledge, Taylor & Francis Group, New York.

69. Mattson, B. J. & Morrell, J. I. (2005). Preference for cocaine-versus pup-associated cues differentially activates neurons expressing either Fos or Cocaine- and Amphetamine-regulated transcript in lactating, maternal rodents. Neuroscience, 135 (2), 315–328.

70. Fletcher, G. J. O. et al. (2015). Pair-bonding, romantic love, and evolution: the curious case of Homo sapiens. Perspectives on Psychological Science, 10 (1), 20–36.

Глава 2. Замороженные деточки: будущее наступило

1. La Marca, A. et al. (2012). Normal serum anti-Mullerian hormone levels in the general female population and the relationship with reproductive history. European Journal of Obstetrics & Gynecology and Reproductive Biology, 163, 180–184.

2. Goswami, M. & Nikolaou, D. (2017). Is AMH level, independent of age, a predictor of live birth in IVF? Journal of Human Reproductive Sciences, 10 (1), 24–30.

3. Visser, J. A. et al. (2006). Anti-Mullerian hormone: a new marker for ovarian function. Reproduction, 131 (1), 1–9.

4. Taylan, E. et al. (2019). Current status of germline stem cells in adult mammalian ovary. Trakya University Journal of Natural Sciences, 20, S63 – S66.

5. Steiner, A. Z. et al. (2016). Impact of female age and nulligravidity on fecundity in an older reproductive age cohort. Fertility and Sterility, 105 (6), 1584–1588.

6. Thurston, L. et al. (2019). Investigation and management of subfertility. Journal of Clinical Pathology, 72 (9), 579–587.

7. Fleming, R. et al. (2015). Assessing ovarian response: antral follicle count versus anti-Mullerian hormone. Reproductive Biomedicine Online, 31, 486–496.

8. Wallace, W. H. B. & Kelsey, T. W. (2010). Human ovarian reserve from conception to the menopause. PLOS One, 5 (1), e8772.

9. Laufer, N. et al. (2004). Successful spontaneous pregnancies in women older than 45 years. Fertility and Sterility, 81 (5), 1328–1332.

10. Gleicher, N. et al. (2018). Older women using their own eggs? Issue framed with two oldest reported IVF pregnancies and a live birth. Reproductive Biomedicine Online, 37 (2), 172–177.

11. Yeh, J. S. et al. (2014). Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology. Fertility and Sterility, 101 (5), 1331–1336.

12. Salmeen, K. et al. (2011). The oldest gravidas: a review of pregnancy risks in women over 45. Obstetrical & Gynecological survey, 66 (9), 580–590.

13. Simchen, M. J. et al. (2006). Pregnancy outcome after age 50. Obstetrics & Gynecology, 108 (5), 1084–1088.

14. McIntyre, H. D. et al. (2019). Gestational diabetes mellitus. Nature Reviews Disease Primers, 5 (1), 47.

15. Calhaz-Jorge, C. et al. (2020). Survey on ART and IUI: legislation, regulation, funding and registries in European countries: the European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embtyology (ESHRE). Human Reproduction Open, 1, hoz044.

16. Farquhar, C. et al. (2018). Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomized, controlled, two-centre trial. Lancet, 391 (10119), 441–450.

17. Farquhar, C. & Marjoribanks, J. (2018). Assisted reproductive technology: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews, 8, CD010537.

18. Geber, S. (2002). Laboratory techniques for human embryos. Reproductive Biomedicine Online, 5 (2), 211–218.

19. Edwards, R. G. et al. (1980). Establishing full-term human pregnancies using cleaving embryos grown in vitro. British Journal of Obstetrics and Gynaecology, 87 (9), 737–756.

20. Yovich, J. L. & Craft, I. L. (2018). Foundling pioneers of IVF: independent innovative researchers generating livebirths within 4 years of the first birth. Reproductive Biology, 18, 317–323.

21. Fauser, B. (2018). Towards the global coverage of a unified registry of IVF outcomes. Reproductive Biomedicine Online, 38 (2), 133–137.

22. Alper, M. M. & Fauser, B. C. (2017). Ovarian stimulation protocols for IVF: is more better than less? Reproductive Biomedicine Online, 34 (4), 345–353.

23. Youssef, M. et al. (2014). Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in agonist-assisted reproductive technology. Cochrane Database of Systematic Reviews, 10, CD008046.

24. Nagy, Z. P. et al. (2020). Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment. Fertility and Sterility, 113 (2), 241–247.

25. Roque, M. et al. (2017). Freeze-all cycle in reproductive medicine: current perspectives. JBRA Assisted Reproduction, 21 (1), 49–53.

26. Iussig, B. et al. (2019). A brief history of oocyte cryopreservation: arguments and facts. Acta Obstetricia et Gynecologica Scandinavica, 98 (5), 550–558.

27. Son, W-Y. & Tan, S. L. (2009). Comparison between slow freezing and vitrification for human embryos. Expert Review of Medical Devices, 6 (1), 1–7.

28. Kuwayama, M. et al. (2005). Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reproductive Biomedicine Online, 11 (5), 608–614.

29. Levi-Setti, P. E. et al. (2014). Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007–2011. Fertility and Sterility, 102 (1), 90–95.

30. Сhen, M. & Heilbronn, L. K. (2017). The health outcomes of human offspring conceived by assisted reproductive technologies (ART). Journal of Developmental Origins of Health and Disease, 8 (4), 388–402.

31. Bankowski, B. J. et al. (2005). The social implications of embryo cryopreservation. Fertility and Sterility, 84 (4), 823–832.

32. Inhorn, M. C. et al. (2018). Ten pathways to elective egg freezing: a binational analysis. Journal of assisted reproduction and genetics, 35 (11), 2003–2011.

33. Alteri, A. et al. (2018). Elective egg freezing without medical indications. Acta Obstetricia et Gynecologica Scandinavica, 98, 647–652.

34. Mesen, T. B. et al. (2015). Optimal timing for elective egg freezing. Fertility and Sterility, 103 (6), 1551–1556.

35. Doyle, J. O. et al. (2016). Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertility and sterility, 105 (2), 459–466.

36. Goldman, R. H. et al. (2017). Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Human Reproduction, 32 (4), 853–859.

Глава 3. Вера в генетику и границы ее применимости

1. Segal, N. L. (2017). Twins reared together and apart: the science behind the fascination. Proceedings of the American Philosophical Society, 161 (1), 1–17.

2. Grimes, W. (2015). Jack Yufe, a Jew whose twin was a Nazi, dies at 82. The New York Times, Nov. 13. https://www.nytimes.com/2015/11/14/us/jack-yufe-a-jew-whose-twin-was-a-nazi-dies-at-82.html

3. Bouchard, J. T. et al. (1990). Sources of human psychological differences: the Minnesota study of twins reared apart. Science, 250 (4978), 223–228.

4. Van Dongen, J. et al. (2012). The continuing value of twin studies in the omics era. Nature Reviews Genetics, 13 (9), 640–653.

5. Tenesa, A. & Haley, C. S. (2013). The heritability of human disease: estimation, uses and abuses. Nature Reviews Genetics, 14 (2), 139–149.

6. Derks, E. M. et al. (2006). A test of the equal environment assumption in multivariate twin studies. Twin Research and Human Genetics, 9 (3), 403–411.

7. Gabbett, M. T. et al. (2019). Molecular support for heterogonesis resulting in sesquizygotic twinning. The New England Journal of Medicine, 380, 842–829.

8. Polderman, T. J. C. et al. (2015). Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nature Genetics, 47, 702–709.

9. Sanders, A. R. et al. (2017). Genome-wide association study of male sexual orientation. Scientific reports, 7, 16950.

10. Hatemi, P. K. et al. (2014). Genetic influences on political ideologies: twin analyses of 19 measures of political ideologies from five democracies and genome-wide findings from three populations. Behavior Genetics, 44 (3), 282–294.

11. Young, A. I. (2019). Solving the missing heritability problem. PLOS Genetics, 15 (6), e1008222.

12. Purves, D. et al. (2012). Neuroscience. 5th edition. Sunderland, Massachusetts: Sinauer Associates, Inc.

13. Negi, S. K. & Guda, C. (2017). Global gene expression profiling of healthy human brain and its application in studying neurological disorders. Scientific Reports, 7 (1), 897.

14. Wen, L. et al. (2016). Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism. Molecular Neurobiology, 53 (1), 472–484.

15. Byrd, A. L. & Manuck, S. B. (2014). MAOA, childhood maltreatment and antisocial behavior: meta-analysis of a gene-environment interaction. Biological Psychiatry, 75 (1), 9–17.

16. Plomin, R. et al. (2016). Top 10 replicated findings from behavioral genetics. Perspectives on Psychological Science, 11 (1), 3–23.

17. Casonato, M. & Habersaat, S. (2015). Parenting without being genetically connected. Enfance, 3, 289–306.

18. Kirkman-Brown, J. C. & Martins, M. V. (2020). ‘Genes versus children’: if the goal is parenthood, are we using the optimal approach? Human Reproduction, 35 (1), 5–11.

19. Gezinski, L. B. et al. (2016). Exploring motivations, awareness of side effects, and attitudes among potential egg donors. Health & Social Work, 41 (2), 75–83.

20. Golombok, S. (2021). Love and truth: what really matters for children born through third-party assisted reproduction. Child Development Perspectives, 15 (2), 103–109.

21. Malm, K. & Welti, K. (2010). Exploring Motivations to Adopt. Adoption Quarterly, 13, 185–208.

22. Ijzendoorn, M. H. & Juffer, F. (2005). Adoption is a successful natural intervention enhancing adopted children’s IQ and school performance. Current Directions in Psychological Science, 14 (6), 326–330.

23. Cheesman, R. et al. (2020). Comparison of adopted and nonadopted individuals reveals gene-environment interplay for education in the UK Biobank. Psychological Science, 31 (5), 582–591.

24. Kendler, K. S. et al. (2016). The rearing environment and risk for drug abuse: a Swedish national high-risk adopted and not adopted co-sibling control study. Psychological Medicine, 46 (7), 1359–1366.

25. Kendler, K. S. et al. (2016). Criminal offending and the family environment: Swedish national high-risk home-reared and adopted-away co-sibling control study. The British Journal of Psychiatry, 209, 294–299.

26. Kendler, K. S. et al. (2015). Triparental families: a new genetic-epidemiological design applied to drug abuse, alcohol use disorders, and criminal behavior in a Swedish national sample. The American Journal of Psychiatry, 172 (6), 553–560.

27. Julian, M. M. (2013). Age at adoption from institutional care as a window into the lasting effects of early experiences. Clinical Child and Family Psychology Review, 16 (2), 101–145.

28. Decker, S. & Omori, M. (2009). Age of adoption: long-term measures of success in adulthood. Adoption Quarterly, 12, 37–52.

Глава 4. Чем беременный человек отличается от обычного

1. Bainbridge, D. R. J. (2014). The evolution of pregnancy. Early Human Development, 90 (11), 741–745.

2. Whittington, C. M. et al. (2022). Embryonic specializations for vertebrate placentation. Phylosophical Transactions of the Royal Society B, Biological Sciences, 377 (1865), 20210261.

3. Renfree, M. B. (2010). Review: Marsupials: placental mammals with a difference. Placenta, 31, S21 – S26.

4. Blackburn, D. G. (2015). Evolution of vertebrate viviparity and specializations for fetal nutrition: a quantitative and qualitative analysis. Journal of Morphology, 276 (8), 961–990.

5. Chavan, A. R. et al. (2017). The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend. Current Opinion in Genetics & Development, 47, 24–32.

6. Maltepe, E. & Fisher, S. (2015). Placenta: the forgotten organ. The Annual Review of Cell and Developmental Biology, 31, 523–552.

7. Chuong, E. B. (2013). Retroviruses facilitate the rapid evolution of the mammalian placenta. Bioessays, 35 (10), 853–861.

8. Cassidy, F. C. & Charalambous, M. (2018). Genomic imprinting, growth, and maternal-fetal interactions. Journal of Experimental Biology, 221 (S1), jeb164517.

9. Millership, S. J. et al. (2019). Genomic imprinting and its effects on postnatal growth and adult metabolism. Cellular and Molecular Life Sciences, 76, 4009–4021.

10. Dini, P. et al. (2021). Parental bias in expression and interaction of genes in the equine placenta. PNAS, 118 (16), e2006474118.

11. Imakawa, K. et al. (2022). Endogenous retroviruses and placental evolution, development, and diversity. Cells, 11, 2458.

12. Jaremek, A. et al. (2021). Omics approaches to study formation and function of human placental syncytiotrophoblast. Frontiers in Cell and Developmental Biology, 9, 674162.

13. Perez-Munoz, M. E. et al. (2017). A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome, 5, 48.

14. Denner, J. (2016). Expression and function of endogenous retroviruses in the placenta. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 124 (1–2), 31–43.

15. Meyer, T. J. et al. (2017). Endogenous retroviruses: with us and against us. Frontiers in Chemistry, 5, 23.

16. Tong, M. & Abrahams, V. M. (2020). Immunology of the placenta. Obstetrics and Gynecology Clinics of North America, 47 (1), 49–63.

17. Mor, G. & Cardenas, I. (2010). The immune system in pregnancy: a unique complexity. American Journal of Reproductive Immunology, 63 (6), 425–433.

18. Piccinni, M. et al. (2016). How pregnancy can affect autoimmune diseases progression? Clinical and Molecular Allergy, 14, 11.

19. Sappenfield, E. et al. (2013). Pregnancy and susceptibility to infectious diseases. Infectious Diseases in Obstetrics and Gynecology, 2013, 752852.

20. Kay, A. W. & Blish, C. A. (2015). Immunogenicity and clinical efficacy of influenza vaccination in pregnancy. Frontiers in Immunology, 6, 289.

21. Jamieson, D. J. & Rasmussen, S. A. (2022). An update on COVID-19 and pregnancy. American Journal of Obstetrics and Gynecology, 226 (2), 177–186.

22. Cole, L. A. (2012). hCG, the wonder of today’s science. Reproductive Biology and endocrinology, 10, 24.

23. Nwabuobi, C. et al. (2017). hCG: biological functions and clinical applications. International Journal of Molecular Sciences, 18, 2037.

24. Tal, R. & Taylor, H. S. Endocrinology of Pregnancy. [Updated 2021 Mar 18]. In: Feingold, K. R., Anawalt, B., Blackman, M. R., et al., editors. Endotext [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK278962/

25. Talbot, L. & Maclennan, K. (2016). Physiology of pregnancy. Anaesthesia & Intensive Care Medicine, 17 (7), 341–345.

26. Costantine, M. (2014). Physiologic and pharmacokinetic changes in pregnancy. Frontiers in Pharmacology, 5, 65.

27. Rassie, K. et al. (2022). Human placental lactogen in relation to maternal metabolic health and fetal outcomes: a systematic review and meta-analysis. International Journal of Molecular Sciences, 23, 15621.

28. Velegrakis, A. et al. (2017). Human placental growth hormone in normal and abnormal fetal growth (review). Biomedical Reports, 7, 115–122.

29. Brunton, P. J. & Russell, J. A. (2010). Endocrine induced changes in brain function during pregnancy. Brain Research, 1364, 198–215.

30. Brown, E. & Schaffir, J. (2019). “Pregnancy brain”: a review of cognitive changes in pregnancy and postpartum. Obstetrical & Gynecological Survey, 74 (3), 178–185.

31. Saltzman, W. & Maestripieri, D. (2012). The neuroendocrinology of primate maternal behavior. Progress in Neuropharmacology and Biological Psychiatry, 35 (5), 1192–1204.

32. McEvoy, K. & Osborne, L. M. (2019). Allopregnanolone and reproductive psychiatry: an overview. International Review of Psychiatry, 31 (3), 237–244.

33. Sundstrom-Poromaa, I. et al. (2020). Progesterone – friend or foe? Frontiers in Neuroendocrinology, 59, 100856.

34. Azhar, Y., Din, A. U. Brexanolone. [Updated 2022 Jun 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK541054/

35. Martinez-Garcia, M. et al (2021). Characterizing the brain structural adaptations across the motherhood transition. Frontiers in Global Women’s Health, 2, 742775.

36. Martinez-Garcia, M. et al (2021). Do pregnancy-induced brain changes reverse? The brain of a mother six years after parturition. Brain Sciences, 11, 168.

37. Aleknaviciute, J. et al (2022). Long-term association of pregnancy and maternal brain structure: the Rotterdam Study. European Journal of Epidemiology, 37, 271–281.

38. Судебная медицина: учебник / под общ. ред. В. Н. Крюкова. 2-е изд., перераб. и доп. М.: Норма, 2009.

39. Ubelaker, D. H. & De La Paz, J. S. (2012). Skeletal indicators of pregnancy and parturition: a historical review. Journal of Forensic Sciences, 57 (4), 866–872.

40. Waltenberger, L. et al. (2022). Are parturition scars truly signs of birth? The estimation of parity in a well-documented modern sample. International Journal of Osteoarchaeology, 32 (3), 619–629.

41. Rosner, M. et al. (2021). Fetomaternal microchimerism and genetic diagnosis: on the origins of fetal cells and cell-free fetal DNA in the pregnant woman. Mutation Research. Reviews in Mutation Research, 788, 108399.

42. Bianchi, D. W. et al. (2021). Forever connected: the lifelong biological consequences of fetomaternal and maternofetal microchimerism. Clinical Chemistry, 67 (2), 351–362.

43. Comitre-Mariano, B. et al. (2021). Feto-maternal microchimerism: memories from pregnancy. iScience, 25 (1), 103664.

44. Breveglieri, G. et al. (2019). Non-invasive prenatal testing using fetal DNA. Molecular Diagnosis & Therapy, 23 (2), 291–299.

45. Paul, L. T. & Ergoren, M. C. (2022). Comparison of bioinformatics approaches for fetal microdeletions and monogenic variations estimation in non-invasive prenatal testing. Global Medical Genetics, 9 (2), 72–75.

Глава 5. Не только запреты, но и привилегии

1. Oladipupo, I. et al. (2022). Association between cigarette smoking and ovarian reserve among women seeking fertility care. PLoS ONE, 17 (12), e0278998.

2. Vanegas, J. C. et al. (2017). Discrete survival model analysis of a couple’s smoking pattern and outcomes of assisted reproduction. Fertility Research and Practice, 3, 5.

3. Meeker, J. D. & Benedict, M. D. (2013). Infertility, pregnancy loss and adverse birth outcomes in relation to maternal secondhand tobacco smoke exposure. Current Women’s Health Reviews, 9 (1), 41–49.

4. Ekblad, M. et al. (2015). Smoking during pregnancy affects foetal brain development. Acta Paediatrica, 104, 12–18.

5. United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking Cessation: A Report of the Surgeon General [Internet]. Washington (DC): US Department of Health and Human Services; 2020. Chapter 4, The Health Benefits of Smoking Cessation. https://www.ncbi.nlm.nih.gov/books/NBK555590/

6. Sailer, S. et al (2019). Impact of nicotine replacement and electronic Rnicotine delivery systems on fetal brain development. International Journal of Environmental Research and Public Health, 16, 5113.

7. Moon, R. Y. et al. (2022). Sleep-related infant deaths: updated 2022 recommendations for reducing infant deaths in the sleep environment. Pediatrics, 150 (1), e2022057990.

8. Liu, B. et al. (2020). Maternal cigarette smoking before and during pregnancy and the risk of preterm birth: a dose-response analysis of 25 million mother-infant pairs. PLOS Medicine, 17 (8), e10031158.

9. Anderson, T. M. et al. (2019). Maternal smoking before and during pregnancy and the risk of sudden unexpected infant death. Pediatrics, 143 (4), e20183325.

10. Leite, M. et al. (2014). Maternal smoking in pregnancy and risk for congenital malformations: results of a Danish register-based cohort study. Acta Obstetricia et Gynecologica Scandinavica, 93 (8), 825–834.

11. Raisanen, S. et al. (2014). Smoking cessation in the first trimester reduces most obstetric risks, but not the risks of major congenital anomalies and admission to neonatal care: a population-based cohort study of 1 164 953 singleton pregnancies in Finland. Journal of epidemiology and community health, 68 (2), 159–164.

12. Adam, M. P. (2012). The all-or-none phenomenon revisited. Birth Defects Research. Part A, Clinical and Molecular Teratology, 94 (8), 664–669.

13. Gilbert-Barness, E. (2010). Review: teratogenic causes of malformations. Annals of Clinical & Laboratory Science, 40 (2), 99–114.

14. Legault, L. M. et al. (2021). Pre-implantation alcohol exposure induces lasting sex-specific DNA methylation programming errors in the developing forebrain. Clinical Epigenetics, 13, 164.

15. Nykjaer, C. et al. (2014). Maternal alcohol intake prior to and during pregnancy and risk of adverse birth outcomes: evidence from a British cohort. Journal of epidemiology and community health, 68 (6), 542–549.

16. Zhou, Q. et al. (2020). Association between preconception paternal smoking and birth defects in offspring: evidence from the database of the National Free Preconception Health Examination Project in China. An International Journal of Obstetrics and Gynaecology, 127 (11), 1358–1364.

17. Wilhoit, L. F. et al. (2017). Fetal alcohol spectrum disorders: characteristics, complications, and treatment. Community Mental Health Journal, 53 (6), 711–718.

18. Feldman, H. S. et al. (2012). Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcoholism: Clinical and Experimental Research, 36 (4), 670–676.

19. Lange, S. et al. (2017). Global prevalence of fetal alcohol spectrum disorder among children and youth. JAMA Pediatrics, 171 (10), 948–956.

20. Popova, S. et al. (2017). Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Global Health, 5, e290–299.

21. Abel, E. L. (2006). Fetal alcohol syndrome: a cautionary note. Current Pharmaceutical Design, 12, 1521–1529.

22. O’Brien, P. (2007). Is it all right for women to drink small amounts of alcohol in pregnancy? Yes. British Medical Journal, 335 (7625), 856.

23. Nathanson, V. et al. (2007). Is it all right for women to drink small amounts of alcohol in pregnancy? No. British Medical Journal, 335 (7625), 857.

24. Armstrong, E. M. (2017). Making sense of advice about drinking during pregnancy: does evidence even matter? The Journal of Perinatal Education, 26 (2), 65–69.

25. Mamluk, L. et al. (2017). Low alcohol consumption and pregnancy and childhood outcomes: time to change guidelines indicating apparently ‘safe’ levels of alcohol during pregnancy? A systematic review and meta-analysis. BMJ Open, 7 (7), e015410.

26. Van Gool, J. D. et al. (2018). Folic acid and primary prevention of neural tube defects: a review. Reproductive toxicology, 80, 73–84.

27. Lee, S. & Gleeson, J. G. (2020). Closing in on mechanisms of open neural tube defects. Trends in Neurosciences, 43 (7), 519–532.

28. Blencowe, H. et al. (2018). Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Annals of the New York Academy of Sciences, 1414 (1), 31–46.

29. Khan, K. M. & Jialal, I. Folic Acid Deficiency. [Updated 2022 Jun 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK535377/

30. Koury, M. J. & Ponka, P. (2004). New insights into erythropoiesis: the roles of folate, vitamin B12, and Iron. Annual Review of Nutrition, 24, 105–131.

31. Greenberg, J. A. et al. (2011). Folic acid supplementation and pregnancy: more than just neural tube defect prevention. Reviews in Obstetrics & Gynecology, 4 (2), 52–59.

32. Li, B. et al. (2019). Folic acid and risk of preterm birth: a meta-analysis. Frontiers in Neuroscience, 13, 1284.

33. Means, R. T. (2020). Iron deficiency and Iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients, 12, 447.

34. Georgieff, M. K. (2020). Iron deficiency in pregnancy. American Journal of Obstetrics & Gynecology, 223 (4), 516–524.

35. Keats, E. C. et al. (2019). Multiple-micronutrient supplementation for women during pregnancy (Review). Cochrane Database of Systematic Reviews, 3, CD00490.

36. Maia, S. B. et al. (2019). Vitamin A and pregnancy: a narrative review. Nutrients, 11, 681.

37. Panchaud, A. et al. (2012). Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study. Journal of Clinical Pharmacology, 52 (12), 1844–1851.

38. Petrelli, B. et al. (2018). Insights into retinoic acid deficiency and the induction of craniofacial malformations and microcephaly in fetal alcohol spectrum disorder. Genesis: the Journal of Genetics and Development, 57 (1), e23278.

39. Olson, J. M., Ameer, M. A., Goyal, A. Vitamin A Toxicity. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532916/

40. WHO (2012). Guideline: Vitamin D supplementation in pregnant women. Geneva, World Health Organization.

41. WHO (2016). WHO recommendations on antenatal care for a positive pregnancy experience. Geneva, World Health Organization.

42. WHO (2020). WHO antenatal care recommendations for a positive pregnancy experience. Nutritional interventions update: Vitamin D supplements during pregnancy. Geneva: World Health Organization.

43. De-Regil, L. M. et al. (2016). Vitamin D supplementation for women during pregnancy. The Cochrane Database of Systematic Reviews, 1, CD008873.

44. Palacios, C. et al. (2019). Vitamin D supplementation for women during pregnancy. The Cochrane Database of Systematic Reviews, 7, CD008873 [Update].

45. Mansur, J. L. et al. (2022). Vitamin D: before, during and after pregnancy: effect on neonates and children. Nutrients, 14, 1900.

46. Morales-Suarez-Varela, M. M. et al. (2022). Vitamin D-related risk factors for maternal morbidity during pregnancy: a systematic review. Nutrients, 14, 3166.

47. Tous, M. et al. (2020). Vitamin D status during pregnancy and offspring outcomes: a systematic review and meta-analysis of observational studies. European Journal of Clinical Nutrition, 74, 36–53.